This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryan, E. T.
Right arrow Articles by Calderwood, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, E. T.
Right arrow Articles by Calderwood, S. B.

 Previous Article  |  Next Article 

Infection and Immunity, April 1999, p. 1694-1701, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae

Edward T. Ryan,1 Thomas I. Crean,1 Manohar John,1 Joan R. Butterton,1 John D. Clements,2 and Stephen B. Calderwood1,3,*

Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 021141; Department of Microbiology and Immunology, Tulane University Medical Center, New Orleans, Louisiana 701122; and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 021153

Received 20 August 1998/Returned for modification 4 November 1998/Accepted 31 December 1998

Vibrio cholerae secretes cholera toxin (CT) and the closely related heat-labile enterotoxin (LT) of Escherichia coli, the latter when expressed in V. cholerae. Both toxins are also potent immunoadjuvants. Mutant LT molecules that retain immunoadjuvant properties while possessing markedly diminished enterotoxic activities when expressed by E. coli have been developed. One such mutant LT molecule has the substitution of a glycine residue for arginine-192 [LT(R192G)]. Live attenuated strains of V. cholerae that have been used both as V. cholerae vaccines and as vectors for inducing mucosal and systemic immune responses directed against expressed heterologous antigens have been developed. In order to ascertain whether LT(R192G) can act as an immunoadjuvant when expressed in vivo by V. cholerae, we introduced a plasmid (pCS95) expressing this molecule into three vaccine strains of V. cholerae, Peru2, ETR3, and JRB14; the latter two strains contain genes encoding different heterologous antigens in the chromosome of the vaccine vectors. We found that LT(R192G) was expressed from pCS95 in vitro by both E. coli and V. cholerae strains but that LT(R192G) was detectable in the supernatant fraction of V. cholerae cultures only. In order to assess potential immunoadjuvanticity, groups of germfree mice were inoculated with the three V. cholerae vaccine strains alone and compared to groups inoculated with the V. cholerae vaccine strains supplemented with purified CT as an oral immunoadjuvant or V. cholerae vaccine strains expressing LT(R192G) from pCS95. We found that mice continued to pass stool containing V. cholerae strains with pCS95 for at least 4 days after oral inoculation, the last day evaluated. We found that inoculation with V. cholerae vaccine strains containing pCS95 resulted in anti-LT(R192G) immune responses, confirming in vivo expression. We were unable to detect immune responses directed against the heterologous antigens expressed at low levels in any group of animals, including animals that received purified CT as an immunoadjuvant. We were, however, able to measure increased vibriocidal immune responses against vaccine strains in animals that received V. cholerae vaccine strains expressing LT(R192G) from pCS95 compared to the responses in animals that received V. cholerae vaccine strains alone. These results demonstrate that mutant LT molecules can be expressed in vivo by attenuated vaccine strains of V. cholerae and that such expression can result in an immunoadjuvant effect.

* Corresponding author. Mailing address: Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114. Phone: 617-726-3811. Fax: 617-726-7416. E-mail: scalderwood{at}partners.org.

Infection and Immunity, April 1999, p. 1694-1701, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Ghose, C., Kalsy, A., Sheikh, A., Rollenhagen, J., John, M., Young, J., Rollins, S. M., Qadri, F., Calderwood, S. B., Kelly, C. P., Ryan, E. T. (2007). Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice. Infect. Immun. 75: 2826-2832 [Abstract] [Full Text]  
  • Rollenhagen, J. E., Kalsy, A., Cerda, F., John, M., Harris, J. B., LaRocque, R. C., Qadri, F., Calderwood, S. B., Taylor, R. K., Ryan, E. T. (2006). Transcutaneous Immunization with Toxin-Coregulated Pilin A Induces Protective Immunity against Vibrio cholerae O1 El Tor Challenge in Mice.. Infect. Immun. 74: 5834-5839 [Abstract] [Full Text]  
  • Glynn, A., Roy, C. J., Powell, B. S., Adamovicz, J. J., Freytag, L. C., Clements, J. D. (2005). Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens. Infect. Immun. 73: 5256-5261 [Abstract] [Full Text]  
  • Kotton, C. N., Hohmann, E. L. (2004). Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery. Infect. Immun. 72: 5535-5547 [Full Text]  
  • Matsui, H., Suzuki, M., Isshiki, Y., Kodama, C., Eguchi, M., Kikuchi, Y., Motokawa, K., Takaya, A., Tomoyasu, T., Yamamoto, T. (2003). Oral Immunization with ATP-Dependent Protease-Deficient Mutants Protects Mice against Subsequent Oral Challenge with Virulent Salmonella enterica Serovar Typhimurium. Infect. Immun. 71: 30-39 [Abstract] [Full Text]  
  • Arrington, J., Braun, R. P., Dong, L., Fuller, D. H., Macklin, M. D., Umlauf, S. W., Wagner, S. J., Wu, M. S., Payne, L. G., Haynes, J. R. (2002). Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coli Are Strong Adjuvants for DNA Vaccines. J. Virol. 76: 4536-4546 [Abstract] [Full Text]  
  • Smith, D. J., King, W. F., Barnes, L. A., Trantolo, D., Wise, D. L., Taubman, M. A. (2001). Facilitated Intranasal Induction of Mucosal and Systemic Immunity to Mutans Streptococcal Glucosyltransferase Peptide Vaccines. Infect. Immun. 69: 4767-4773 [Abstract] [Full Text]  
  • Koprowski, H. II, Levine, M. M., Anderson, R. J., Losonsky, G., Pizza, M., Barry, E. M. (2000). Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli. Infect. Immun. 68: 4884-4892 [Abstract] [Full Text]  
  • Guillobel, H. C. R., Carinhanha, J. I., Cardenas, L., Clements, J. D., de Almeida, D. F., Ferreira, L. C. S. (2000). Adjuvant Activity of a Nontoxic Mutant of Escherichia coli Heat-Labile Enterotoxin on Systemic and Mucosal Immune Responses Elicited against a Heterologous Antigen Carried by a Live Salmonella enterica Serovar Typhimurium Vaccine Strain. Infect. Immun. 68: 4349-4353 [Abstract] [Full Text]  
  • John, M., Crean, T. I., Calderwood, S. B., Ryan, E. T. (2000). In Vitro and In Vivo Analyses of Constitutive and In Vivo-Induced Promoters in Attenuated Vaccine and Vector Strains of Vibrio cholerae. Infect. Immun. 68: 1171-1175 [Abstract] [Full Text]  
  • Crean, T. I., John, M., Calderwood, S. B., Ryan, E. T. (2000). Optimizing the Germfree Mouse Model for In Vivo Evaluation of Oral Vibrio cholerae Vaccine and Vector Strains. Infect. Immun. 68: 977-981 [Abstract] [Full Text]  
  • Ryan, E. T., Crean, T. I., Kochi, S. K., John, M., Luciano, A. A., Killeen, K. P., Klose, K. E., Calderwood, S. B. (2000). Development of a Delta glnA Balanced Lethal Plasmid System for Expression of Heterologous Antigens by Attenuated Vaccine Vector Strains of Vibrio cholerae. Infect. Immun. 68: 221-226 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»